Hua Medicine (Shanghai) Ltd.
HUMDFOTCHealthcare● Active
$0.41
$-0.02(-5.02%)
Market Cap$409270596
P/E Ratio—
52W High$0.5
52W Low$0.15
Hua Medicine (Shanghai) Ltd. (HUMDF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HUMDF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.48B | $0.26B | $0.08B | $0.02B | $0.00B |
| Cost of Revenue | $0.21B | $0.13B | $0.04B | $0.01B | $0.00B |
| Gross Profit | $0.27B | $0.12B | $0.04B | $0.01B | $0.00B |
| Gross Margin %(computed) | 56.87% | 48.74% | 48.78% | 43.69% | — |
| Operating Expenses | |||||
| R&D Expenses | $0.14B | $0.22B | $0.17B | $0.13B | $0.19B |
| G&A Expenses | $0.00B | $0.12B | $0.12B | $0.13B | $0.13B |
| Total Operating Expenses | $0.41B | $0.48B | $0.33B | $0.27B | $0.32B |
| Operating Income | ($0.14B) | ($0.35B) | ($0.29B) | ($0.27B) | ($0.32B) |
| Operating Margin %(computed) | -29.39% | -137.81% | -377.36% | — | — |
| Interest Income | $0.01B | $0.01B | $0.02B | $0.00B | $0.01B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Income Before Tax | $1.08B | ($0.25B) | ($0.21B) | ($0.20B) | ($0.33B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $1.08B | ($0.25B) | ($0.21B) | ($0.20B) | ($0.33B) |
| Net Margin %(computed) | 224.44% | -97.75% | -275.73% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.12 | $-0.25 | $-0.22 | $-0.21 | $-0.34 |
| Wtd Avg Shares | 0.99B | 0.98B | 0.98B | 0.97B | 0.96B |
| EBITDA | ($0.11B) | ($0.21B) | ($0.17B) | ($0.17B) | ($0.31B) |
| EBITDA Margin %(computed) | -22.81% | -80.87% | -218.10% | -954.96% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CNY · B
Explore more Hua Medicine (Shanghai) Ltd. data
About Hua Medicine (Shanghai) Ltd. (HUMDF) Income Statement
Hua Medicine (Shanghai) Ltd. (HUMDF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, HUMDF reported revenue of $0.48B, gross profit of $0.27B (gross margin 56.87%), and net income of $1.08B — a net profit margin of 224.44%.
Frequently asked questions
HUMDF · 4 questionsHua Medicine (Shanghai) Ltd. (HUMDF) reported revenue of $0.48B for 2025, up 87.7% year-over-year.
HUMDF revenueHUMDF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09